The U.S. cannabis industry continues to expand, with over 80% of Americans now supporting some form of legalization. Recent headlines show the DEA is likely to reschedule marijuana from Schedule I to Schedule III. This move could ease tax burdens and promote medical research. Analysts project the legal U.S. cannabis market could surpass $71 billion by 2030. As more states adopt legal programs, smaller companies with growth potential are gaining attention. Therefore, marijuana penny stocks remain attractive to traders looking for high-reward opportunities. However, the sector is still volatile. Investors should combine technical analysis with sound risk management strategies. Look for price support levels, breakout setups, and volume confirmations. Also, use proper stop-loss orders to manage risk. With legalization efforts gaining momentum, short-term spikes are likely. Thus, traders should stay alert this week. Momentum, news catalysts, and chart setups will help identify top entries.

Many catalysts continue to build toward full cannabis legalization in the U.S. The SAFE Banking Act could pass by 2025, providing financial services access to cannabis businesses. Additionally, more states are preparing for ballot initiatives in 2026 and 2028. These changes will likely increase investor interest in cannabis stocks, especially low-priced ones. As the market reacts to legalization news, marijuana penny stocks often show fast moves.

Marijuana Stocks with Rebound Potential

Because of their affordability, these stocks allow exposure with limited capital. However, their volatility requires extra caution. Traders must use chart patterns, moving averages, and volume indicators. Also, focus on entries near support with clear upside targets. Watching for confirmation and avoiding emotional decisions is key. Moreover, stay updated with news developments and legislative updates. As always, use a trade plan with risk parameters in place. This week, several penny stocks are positioned to benefit from current momentum. Let’s review the most promising names now.

As the U.S. cannabis industry gains momentum, investors are eyeing select stocks with growth potential. Federal rescheduling is expected soon, which could reduce operators’ tax burdens and attract institutional capital. The SAFE Banking Act also remains on the table. Meanwhile, consumer demand continues rising in both medical and recreational markets. In this environment, several marijuana companies are positioned for strong performance. The following are three top marijuana stocks to watch in May 2025.

[Read More] Marijuana Market Set to Surge by 2030— Here Are This Week’s Top U.S. Stock Picks

Top Marijuana Stocks to Watch in May 2025

1. Verano Holdings Corp. (OTC: VRNOF)
2. Cansortium Inc. (OTC: CMTNF)
3. Ayr Wellness Inc. (OTC: AYRWF)

Verano Holdings Corp. (VRNOF)

Verano Holdings is a major U.S. multi-state operator with a large retail presence. The company operates over 150 dispensaries nationwide. Florida is its largest market, where it runs more than 80 stores. Verano also has locations in Illinois, New Jersey, and Arizona. The company sells both medical and recreational cannabis under brands like Zen Leaf and MÜV. Its footprint spans 13 states, giving it broad market exposure. This helps Verano adapt to new regulations and consumer demand. The company continues expanding through strategic acquisitions and organic growth. Management has focused on building scale and efficiency across regions. Verano has earned a reputation for premium products and consistent operations. As the industry matures, Verano aims to strengthen its national market share. Its broad retail network provides strong positioning for future U.S. legalization. In May 2025, Verano remains one of the most watched names in cannabis.

Verano’s latest financial results show mixed performance due to market pricing pressure. Quarterly revenue reached $210 million, slightly down from the previous year. Gross profit stood at $100 million, reflecting tighter margins. The company reported an adjusted EBITDA of $54 million. This represented 26% of total revenue, showing stable operating performance. However, the net loss was $12 million, reflecting ongoing challenges. Despite that, Verano produced positive operating cash flow of $2 million. Capital spending totaled $14 million, aimed at upgrading retail facilities. The company remains focused on cutting costs while preserving long-term growth. Verano continues to streamline operations in maturing markets. The balance sheet remains stable, with manageable debt levels. Management expects improved pricing conditions in the second half of 2025. Investors will be watching for signs of margin recovery and stronger cash flow. Overall, Verano remains a solid operator with long-term potential.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

Cansortium Inc. (CMTNF)

Cansortium Inc. is a U.S.-based cannabis company operating under the Fluent brand. Its largest presence is in Florida, with more than 20 dispensaries. The company is vertically integrated, handling cultivation, processing, and retail. Cansortium serves medical cannabis patients with a wide range of products. These include flower, edibles, oils, and capsules. The company is expanding its geographic footprint through strategic partnerships. It has recently entered new markets to diversify revenue streams. Cansortium has focused on building efficiency at its Florida operations. This includes upgrading cultivation facilities to increase output. The company also continues investing in product innovation. Its dispensaries emphasize education and patient experience. Cansortium’s small-cap status makes it attractive to penny stock investors. It offers exposure to Florida’s large and growing medical market. As regulatory momentum builds, this operator could see increased upside. Cansortium remains a stock to watch closely in May 2025.

Financially, Cansortium is focused on improving profitability. The company generated annual revenue of approximately $104 million. This marks steady growth from the previous year. However, earnings remain under pressure with a negative EPS. The company is actively reducing operating costs and increasing production efficiency. Management is working to expand margins and improve free cash flow. Debt levels are moderate, with upcoming maturities being refinanced. Capital expenditures remain conservative to preserve cash reserves. Cansortium is prioritizing core markets while evaluating potential acquisitions. The company continues investing in cultivation infrastructure. It also maintains adequate liquidity for operational needs. Analysts are watching closely for signs of earnings improvement. Strong sales performance in Florida could support positive surprises. As pricing conditions stabilize, Cansortium may return to profitability. Investors should also monitor its expansion into new states. Overall, the company is progressing toward a stronger financial footing in 2025.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Ayr Wellness Inc. (AYRWF)

Ayr Wellness is a vertically integrated cannabis company with operations in several U.S. states. It runs more than 90 licensed dispensaries. Florida is its largest market, followed by Pennsylvania and Massachusetts. Ayr also operates in New Jersey, Nevada, and Illinois. The company continues expanding into Ohio, with several new stores planned. Its brand portfolio includes retail and wellness-based cannabis products. Ayr targets both medical and adult-use customers through tailored offerings. The company focuses on high-quality cultivation and sustainable practices. It invests in staff training, compliance, and patient education. Ayr’s strategic footprint allows access to large and emerging markets. This supports long-term growth as legalization efforts advance. The company has worked to streamline operations and improve efficiency. It aims to be a low-cost producer with premium retail service. Ayr’s footprint, product variety, and operating scale make it a top stock to watch.

Ayr Wellness has taken decisive steps to improve its balance sheet. The company ended 2024 with over $35 million in cash. Operating cash flow reached $9.6 million in the final quarter. Capital expenditures declined to $17.7 million for the year. This helped preserve liquidity and fund core operations. Ayr has focused on cutting debt, reducing interest expenses, and extending maturities. Nearly $400 million in debt was restructured with new terms. Additionally, the company raised new funds through senior note issuance. These moves reduced financial pressure and improved the outlook. Ayr is also focused on revenue growth and margin expansion. New product launches and store openings are expected in 2025. Gross margins remain under pressure but are gradually improving. Ayr’s financial discipline and cost control are key strengths. Investors will be watching for continued revenue growth and stronger profitability. With an improving financial base, Ayr remains well-positioned in the cannabis space.

U.S. Weed Stocks to Track Before the Next Breakout

In conclusion, these three companies—Verano, Cansortium, and Ayr Wellness—stand out for their operational scale and strategic expansion. Each has faced market challenges but continues to position itself for long-term growth. As federal reform efforts progress, these stocks may offer substantial upside. Traders and investors should continue tracking performance, technical levels, and news-driven catalysts in May 2025.

The post Top U.S. Marijuana Stocks to Add to Your Watchlist Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to expand rapidly as legalization gains momentum nationwide. By 2030, the market is expected to grow to over $76 billion. In 2025 alone, cannabis sales could surpass $35 billion across both medical and recreational markets. Additionally, the industry’s total economic impact may exceed $120 billion when accounting for jobs, taxes, and supply chains. Today, 24 states have legalized adult-use cannabis. Meanwhile, 38 states support medical marijuana programs. This widespread adoption reflects shifting public opinion and policy reform. As demand rises, leading cannabis companies are scaling operations quickly. Investors are watching closely for the next breakout opportunity. This week, several top marijuana stocks are showing strong potential. Their momentum could be fueled by expanding retail networks and strategic market positioning. With the industry on track for long-term growth, timing the right entry is key. Therefore, understanding current technical setups becomes increasingly important.

Legal Cannabis in Focus

As legalization advances, federal rescheduling of cannabis remains a major catalyst. If reclassified, companies could benefit from improved tax treatment and expanded banking access. This change would ease financial burdens and boost long-term profitability. However, risks remain. Regulatory hurdles, local bans, and pricing pressure still impact margins. Therefore, investors must remain cautious and use sound strategies.

Technical analysis can help pinpoint trends and potential reversals. Key indicators such as moving averages, RSI, and volume spikes offer valuable signals. At the same time, proper risk management is essential. This includes setting stop-losses and maintaining position size discipline. Investors should also watch industry news and policy updates closely. These changes can quickly shift market sentiment. As the cannabis space evolves, adaptability and research will remain critical. This week, several U.S.-based stocks stand out due to recent price action and favorable positioning. Tracking their movement may offer strong opportunities in a rapidly growing sector.

As the U.S. cannabis industry continues to expand rapidly, investors are closely watching which companies will benefit most. With projections showing the market reaching tens of billions by 2030, companies with strong infrastructure, broad retail footprints, and healthy balance sheets stand to gain. In May 2025, three standout U.S.-based cannabis companies to watch include Trulieve Cannabis Corp., Curaleaf Holdings, Inc., and Green Thumb Industries Inc. Each company offers unique strengths that position them well for the future.

[Read More] 2025’s Best Cannabis REITs for Building Wealth Over Time

2025 Cannabis Watchlist: U.S. Marijuana Stocks With Big Growth Potential

1. Trulieve Cannabis Corp. (OTC: TCNNF)
2. Curaleaf Holdings, Inc. (OTC: CURLF)
3. Green Thumb Industries Inc. (OTC: GTBIF)

Trulieve Cannabis Corp. (TCNNF)

Trulieve Cannabis Corp. is one of the most established cannabis companies in the United States. It has built a strong reputation for quality and operational efficiency. The company is headquartered in Florida, where it holds a dominant position in the medical marijuana market. Trulieve currently operates more than 180 dispensaries nationwide, most of which are located in Florida, where the company controls nearly half of the market.

Over time, Trulieve has expanded into 11 states, including Pennsylvania and Arizona. This expansion allows it to tap into both medical and adult-use markets. The company follows a vertical integration model. It controls everything from cultivation to distribution, which ensures consistency and cost savings. Trulieve’s focus on operational excellence has helped it build a loyal customer base. Its strong retail footprint and efficient structure make it a key player in the cannabis sector.

Financial Overview

Trulieve reported impressive results in the first quarter of 2025. Revenue increased 12% year-over-year, reaching approximately $298 million. This growth reflects strong consumer demand and efficient scaling efforts. The company’s gross margin stood at 60%, which indicates effective cost control. Adjusted EBITDA came in at $100 million, showcasing solid operational performance.

Trulieve also reported $150 million in cash and equivalents. This healthy cash position gives the company the flexibility to invest in growth. With expanding profit margins and a disciplined financial strategy, Trulieve is positioned for long-term success. It remains a top stock to watch in the cannabis space this month.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

Curaleaf Holdings, Inc. (CURLF)

Curaleaf Holdings, Inc. is the largest cannabis company in the United States by total revenue. The company is headquartered in New York and operates in 19 states. It runs over 150 retail dispensaries and has 29 cultivation and production facilities. This gives Curaleaf one of the most extensive footprints in the industry.

Curaleaf serves both medical and adult-use customers with a broad range of products. These include cannabis flower, edibles, tinctures, and topicals. Over the past few years, the company has expanded rapidly through multiple strategic acquisitions. These deals have boosted its presence in high-growth markets and enhanced its brand portfolio. Curaleaf’s dedication to innovation and R&D helps it stay ahead of competitors in both product quality and variety.

Financial Overview

In the first quarter of 2025, Curaleaf reported revenue of $420 million. This marks a 15% increase from the same period last year. The company’s gross profit margin rose to 55%, reflecting solid cost control and supply chain efficiency. Adjusted EBITDA reached $110 million, underlining its profitability and strong business execution.

Curaleaf also holds $200 million in cash reserves. This robust financial position supports continued expansion efforts. With increasing sales, healthy margins, and a strong balance sheet, Curaleaf remains well-prepared for future growth. It is a top cannabis stock for investors to keep on their radar in May.

[Read More]  Top Marijuana Stocks In A Volatile Market

Green Thumb Industries Inc. (GTBIF)

Green Thumb Industries Inc. is another major U.S. cannabis company with a growing national presence. Headquartered in Chicago, Green Thumb operates more than 100 dispensaries across 14 states. Most of its retail locations run under the RISE brand, which has gained strong consumer recognition. The company also operates 20 production facilities, allowing for full control of the supply chain.

Green Thumb has created a diverse lineup of product brands. These brands serve both wellness-focused and recreational consumers. Its approach to targeting limited-license states helps the company reduce competition. Green Thumb’s combination of operational scale and retail experience gives it a strong advantage in the U.S. cannabis market. The company continues to expand cautiously, focusing on high-return markets and efficiency.

Financial Overview

Green Thumb posted solid financial results for the first quarter of 2025. Total revenue reached $310 million, a 10% gain from the previous year. The company’s gross margin came in at 58%, signaling good cost management. Adjusted EBITDA was $90 million, indicating consistent profitability and disciplined growth.

Green Thumb also reported having $180 million in cash and equivalents. This strong liquidity supports its expansion strategy and long-term investment goals. The company remains focused on margin improvement and scalable growth. With a steady financial base and disciplined execution, Green Thumb is a strong contender in the cannabis industry and one of the best stocks to watch this month.

Cannabis Stocks Poised for Growth

The U.S. cannabis industry is entering a new phase of maturity; moreover, strong growth projections lie ahead. Companies like Trulieve, Curaleaf, and Green Thumb have already built the scale and infrastructure to thrive in this environment. In addition, their consistent financial performance and expanding operations make them top stocks to monitor in May 2025. As a result, these companies are well-positioned for future gains. Furthermore, as legalization continues and demand rises, these companies could deliver long-term value for investors.

The post Marijuana Market Set to Surge by 2030—Here Are This Week’s Top U.S. Stock Picks appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stock investors are working to stay poised during this ongoing volatile downtrend. Now even though the public sector is in a downtrend has not stopped industry progression as companies continue to generate large amounts of revenue. The cannabis industry has seen significant advancements in 2025. Much of which has been marked by increased and improved legalization. In addition to more companies working with technological innovations, and an expanding health and wellness market with cannabis as the focus.

More states and countries are recognizing the potential economic benefits of cannabis. With this, an increase in the growing number of regions have legalized both medicinal and recreational use. This expanded legal framework has attracted major investors which is why the frustrations are at an all-time high with the public sector. To enhance the trading performance of cannabis stocks, several scenarios could be beneficial. Firstly, greater transparency and standardization in product labeling can build consumer trust and confidence in cannabis products.

Additionally, enhancing regulatory clarity can attract institutional investors who have previously avoided the sector due to legal uncertainties. All of the above play a factor in trusting the market regardless of what is occurring. It is a classic risk vs reward with how things are in the sector. Nevertheless, there is still optimistic speculation for some shareholders and investors. Below are several marijuana stocks to watch and learn about over the Memorial Day break.

Marijuana Stocks To Know About In 2025

1. Leafly Holdings, Inc. (OTC:LFLY)
2. WM Technology, Inc. (NASDAQ:MAPS)
3. High Tide Inc. (NASDAQ:HITI)

Leafly Holdings, Inc.

Leafly Holdings, Inc. operates as an online cannabis discovery marketplace and resource in the United States and internationally. It has been a bit of time since the company has released any current updates.

However, on January 16th, the company held a receipt of notice of delisting from the Nasdaq and transition to OTC market.

WM Technology, Inc.

WM Technology, Inc., an online cannabis marketplace, provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. On May 8th the company reported its Q1 2025 results.

First Quarter 2025 Financial Highlights

• Revenues for the first quarter ended March 31, 2025 was $44.6 million as compared to $44.4 million in the prior year period.
• Average monthly paying clients(1) of 5,179 increased from 4,937 in the prior year period, largely due to new client acquisitions across certain markets.
• Net income increased to $2.5 million from $2.0 million in the prior year period.
• Adjusted EBITDA(3) increased to $10.1 million from $9.6 million in the prior year period.

[Read More] Top Marijuana Stocks In A Volatile Market

Words From The Company

“Our first quarter results reflect focused execution in what remains a challenging environment for the cannabis industry,” said Doug Francis, CEO of WM Technology. ”

[Read More] 2025’s Best Cannabis REITs for Building Wealth Over Time

High Tide Inc.

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. It operates through Bricks and Mortar Operations; and E-commerce Operations segments.

In recent news the company announced the opening of new Canna Cabana store in Cornwall, Ontario. This opening brings High Tide’s total store count to 197 Canna Cabana branded locations across Canada, and 81 in the province of Ontario.

The post 3 Marijuana Stocks That Could Be The Long Term Money Maker appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry remains on a strong growth path, with projections estimating a $45 billion market in 2025. More than 20 states now allow adult recreational cannabis use, while others continue expanding medical programs. Recently, lawmakers have debated cannabis reform at the federal level, including rescheduling cannabis to a lower-risk drug classification. This shift could bring major tax relief and open new financial opportunities for cannabis companies. Despite challenges, these changes are fueling optimism across the sector. Penny stocks in this space offer low entry prices and potential for large percentage gains. As the market responds to legislative updates, investor attention has increased on smaller-cap cannabis plays with aggressive growth plans.

Although these stocks carry promise, they also come with significant risks. Many are highly volatile and trade with low daily volume. For this reason, using technical analysis is crucial when watching or trading marijuana penny stocks. Traders should examine key support and resistance levels. It is also smart to use volume indicators and trend confirmation tools. Setting stop-loss orders and managing position sizes can reduce exposure to large losses. Since these stocks can react sharply to news, disciplined entries and exits are essential. Investors must stay alert, follow news catalysts, and apply sound risk strategies. With the right tools and timing, opportunities in marijuana penny stocks can be substantial.

U.S. Cannabis Stocks to Add to Your Radar Now

As the U.S. cannabis industry continues expanding, investors are closely watching select leaders in the sector. In addition, more states are pushing for legalization, which adds to investor optimism. As a result, top-performing marijuana companies are gaining momentum in the market. This article focuses on three U.S. marijuana stocks worth watching in May 2025: Planet 13 Holdings (PLNH), Glass House Brands (GLASF), and Cresco Labs (CRLBF).

Each of these companies has a strong presence in key U.S. markets. They also continue to evolve operationally while navigating regulatory developments. Despite short-term volatility, these stocks have shown resilience and potential for long-term growth. Below is a closer look at each of these top cannabis players, their U.S. dispensary presence, and their latest financial performance.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Top U.S. Marijuana Stocks to Watch in May 2025

1. Planet 13 Holdings Inc. (OTC: PLNH)
2. Glass House Brands Inc. (OTC: GLASF)
3. Cresco Labs Inc. (OTC: CRLBF)

Planet 13 Holdings Inc. (PLNH)

Planet 13 Holdings is best known for operating the largest cannabis dispensary in the world. This flagship location is in Las Vegas, Nevada, and spans over 112,000 square feet. The store offers a unique retail experience that blends cannabis shopping with interactive entertainment. Tourists and locals alike visit the store daily, making it a high-traffic location.

The company has also expanded into Florida, which remains one of the fastest-growing medical cannabis markets. Currently, Planet 13 operates 30 dispensaries throughout Florida. It also has one location in Illinois, bringing its total count to 32 dispensaries. Its expansion strategy focuses on large-scale stores in high-demand regions. This allows the company to maintain brand recognition and customer loyalty.

With its growing footprint and strong consumer appeal, Planet 13 remains one of the most prominent names in the cannabis industry. Its multi-state operations continue to drive future growth opportunities.

Latest Financials

In its most recent quarterly report, Planet 13 posted revenue of $28 million. This marked a notable increase from the prior year’s results. The rise in revenue was largely driven by sales in Florida and continued strength in Las Vegas. Gross profits came in at $12 million, with a gross margin just above 42 percent.

Despite solid revenue growth, the company reported a net loss of $2 million. This was due to higher operating expenses tied to expansion efforts. Its adjusted EBITDA showed a loss of $2.5 million. However, management emphasized that short-term losses were strategic. The focus remains on building long-term value through market growth.

Planet 13 has sufficient liquidity to support future investments. Management is optimistic about Florida’s contribution to revenue in future quarters. Overall, the company is positioning itself for improved profitability as it scales.

[Read More] Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025

Glass House Brands Inc. (GLASF)

Glass House Brands is a vertically integrated cannabis company based in California. The company focuses exclusively on operations within the state. It operates greenhouse cultivation, manufacturing, distribution, and retail stores. This end-to-end control gives the company strong cost advantages.

The company has multiple dispensaries under its Farmacy brand. Most of these stores are located in high-traffic areas in Southern California. In total, Glass House operates eight dispensaries throughout the state. The company is known for its high-quality, sun-grown cannabis. Its cultivation facilities are among the largest in the country.

Glass House continues to expand its greenhouse capacity. This allows it to scale production without significantly increasing costs. The company’s strategy is rooted in operational efficiency and product consistency. As a result, it has become a leader in California’s highly competitive cannabis market. Its premium brand is well recognized by both medical and recreational consumers.

Latest Financials

In its latest earnings report, Glass House generated $44.8 million in revenue, a strong year-over-year increase driven by volume growth. Seasonal demand fluctuations and wholesale pricing pressures impacted the company’s performance, but it managed to maintain growth in core retail locations.

Gross margins remained relatively stable compared to the prior quarter. However, net losses were reported due to temporary increases in labor and facility costs. Management continues to emphasize its commitment to cost control. The company is also investing in automation to enhance productivity.

Cash reserves remain healthy and support ongoing expansion plans. While short-term headwinds persist in the California market, Glass House maintains its long-term bullish outlook. Its large cultivation assets provide a strong advantage. The company believes scale and quality will drive future margins. Therefore, investors continue to monitor Glass House as a top West Coast player.

[Read More]  These Cannabis Stocks Could Pay Off Big In The Future

Cresco Labs Inc. (CRLBF)

Cresco Labs is a multi-state cannabis operator based in Chicago, Illinois. The company is vertically integrated and offers products across nine key U.S. states. Its retail presence includes states like Florida, Illinois, Pennsylvania, and Massachusetts. Cresco Labs markets its dispensaries under the “Sunnyside” brand.

As of May 2025, Cresco operates 71 dispensaries across six states. Its stores are strategically located in both high-density urban centers and suburban areas. The company also owns several well-known consumer cannabis brands. These brands cater to a wide range of user preferences.

Cresco Labs has focused heavily on market depth rather than broad expansion. It prioritizes establishing strong brand loyalty in each region. This approach allows for efficient scaling and better customer service. The company’s mission is to normalize cannabis use through consistent and professional experiences. Cresco remains one of the largest cannabis companies by retail footprint in the U.S.

Latest Financials

Cresco Labs has delayed the release of its Q1 2025 earnings. However, previous performance trends provide some insight. In its last reported quarter, the company generated revenue of over $190 million, supported by strong retail performance in Florida and Illinois.

Gross profit margins hovered around 50 percent, consistent with prior quarters. The company previously reported a net loss, largely due to one-time restructuring costs. However, the adjusted EBITDA remained positive, showing that the business is generating operating cash flow.

Management has reaffirmed its commitment to reducing costs and improving margins. It is also working to optimize its supply chain. The delayed report is expected to include updates on the restructuring’s progress. Despite short-term challenges, Cresco remains financially stable. It continues to focus on market leadership in limited-license states.

U.S. Cannabis Stocks Catching Investor Attention This Week

In conclusion, the U.S. cannabis sector remains a dynamic and evolving space filled with both risk and opportunity. As legalization efforts continue across the country, investor interest in marijuana stocks is expected to grow. Companies like Planet 13, Glass House Brands, and Cresco Labs are positioning themselves for long-term success through strategic expansion and brand development. However, due to market volatility, it is essential to apply technical analysis and manage risk carefully.

Monitoring price action, volume, and key levels can help identify smarter entry points. Setting stop-losses and staying informed on regulatory changes will also support better decision-making. With proper research and a disciplined approach, investors can capitalize on momentum in this exciting sector. As always, focus on strong fundamentals, clear trends, and market-moving news to maximize cannabis-related opportunities. Now is the time to watch these top marijuana stocks as the U.S. industry moves toward broader acceptance.

The post Top Performing U.S. Marijuana Stocks to Watch in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

In recent weeks, cannabis penny stocks have attracted cautious investor interest. First, the U.S. legal cannabis market reached $33.6 billion in 2023. Moreover, it is projected to grow at a 12.1 percent CAGR through 2030. Meanwhile, employment in the sector surpassed 440,000 full‑time jobs nationwide. At the same time, federal reform remains stalled despite rescheduling momentum. For instance, the DEA’s proposed move to Schedule III could reshape banking access. In addition, states push new bills. Notably, Pennsylvania lawmakers debate privatized dispensaries to unlock $250 million in annual tax revenue. Likewise, the Supreme Court’s recent RICO decision heightens compliance risks across the industry. Therefore, cannabis penny stocks offer both opportunity and volatility this week. Consequently, traders should combine fundamental awareness with market context before entry.

Furthermore, technical analysis can guide precise entry and exit points. For example, watch for clear breakouts above key moving averages. Likewise, identify volume spikes on relative strength index (RSI) signals near oversold levels. At the same time, set stop-loss orders below recent swing lows to limit downside. Moreover, position sizing based on a fixed percentage of portfolio capital prevents outsized losses. In addition, traders should monitor broader market correlations to cannabis ETFs and equities.

Meanwhile, avoid headline risks, such as state-level vetoes or federal delays. Finally, combine chart patterns—like double bottoms or bullish engulfing candles—with strict risk rules. By doing so, investors can pursue gains in penny stocks while containing exposure in this still-evolving industry.

[Read More] These Cannabis Stocks Could Pay Off Big In The Future

Top U.S. Marijuana Stocks to Watch in May 2025

The Cannabist Company Holdings Inc. (OTC: CBSTF)

Cansortium Inc. (OTC: CNTMF) – Doing Business as Fluent

Verano Holdings Corp. (OTC: VRNOF)

The Cannabist Company Holdings Inc. (OTC: CBSTF)

The Cannabist Company, previously known as Columbia Care, is one of the largest vertically integrated cannabis firms in the U.S. Its largest presence is in Florida, New York, and Virginia. As of May 2025, it operates 67 dispensaries across 14 U.S. states. In addition, the company runs 17 cultivation and processing facilities. It offers branded products through in-house lines like Triple Seven and Seed & Strain. Its retail stores are focused on a consistent customer experience. Furthermore, the company has embraced digital marketing and loyalty programs. This helps build stronger customer retention. Recently, it has closed underperforming locations in saturated markets. At the same time, it is focusing on growing markets with long-term upside. These strategic shifts aim to boost margins and reduce overhead. The company focuses on improving operations, scaling sustainably, and navigating changing regulations.

In Q1 2025, the Cannabist Company reported $87 million in revenue. This was slightly lower than the same quarter last year. However, the company improved gross margins by reducing operational costs and optimizing cultivation. Management also reduced SG&A expenses. This improved operational efficiency across its footprint. The net loss narrowed meaningfully compared to the prior year. Additionally, the company successfully restructured a portion of its debt. Lower interest costs are expected in future quarters. Adjusted EBITDA showed improvement, even with modest revenue softness. Cash from operations turned positive for the first time in several quarters. This is a key sign of improving financial health. Liquidity also improved due to better inventory management. Looking forward, management expects stabilization through the second half of 2025. As a result, the company is well-positioned to benefit from future industry growth.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

 Cansortium Inc. (OTC: CNTMF) – Doing Business as Fluent

Cansortium Inc., now operating as Fluent, is a medical marijuana operator with a strong Florida focus. The company currently operates over 30 dispensaries in Florida alone. Outside Florida, it operates in Texas, Pennsylvania, and New York. Fluent also recently expanded into Ohio, adding several co-located dispensaries. Its brand is built on wellness and customer education. Many locations offer pharmacist-led consultations. This builds trust and improves patient experience. Fluent offers a wide range of products. These include flower, concentrates, tinctures, and pre-rolls. The company continues to grow by adding high-performing retail sites in emerging markets. It also seeks joint ventures and local partnerships to reduce entry barriers. With a vertically integrated model, it controls the supply chain from seed to sale. This gives it pricing flexibility and operational consistency. Fluent remains committed to steady, profitable growth in medically focused markets.

Fluent posted $63.8 million in revenue for Q1 2025. This marked a slight decline year-over-year. Retail sales fell slightly due to price compression, though overall unit volume increased. Wholesale sales declined as bulk deals slowed in some markets. However, states like Virginia and Ohio posted strong retail gains. Gross profit came in at $25.8 million, with margins compressed slightly from prior quarters. Operating expenses totaled $27.6 million, which was a modest improvement. Fluent reported a net loss of $17 million in Q1. Interest expenses and depreciation continued to weigh on results. However, adjusted EBITDA was $9.8 million, down from $13.3 million in the previous year. Despite short-term softness, the company’s financials are stabilizing. Investments in Ohio and Virginia are expected to deliver growth in future quarters. Fluent is also improving cash flow and reducing non-essential costs. These steps should help strengthen its financial foundation.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Verano Holdings Corp. (OTC: VRNOF)

Verano Holdings is a major multi-state cannabis operator based in Chicago. It operates in 16 U.S. states and serves both medical and adult-use markets. As of May 2025, Verano runs more than 100 dispensaries. Its largest retail presence is in Florida, Illinois, and Nevada. Verano is known for its premium retail brands like Verano and MÜV. These stores are highly curated and focus on customer experience. The company also owns cultivation and processing facilities in key states. It uses vertical integration to manage costs and ensure consistent product quality. Verano expands through both organic growth and acquisitions. Recent moves have focused on acquiring licenses in underserved regions. It also partners with local operators to reduce risk. Leadership has emphasized careful scaling and integration. As a result, the brand reputation remains strong across regions. The company’s structure supports long-term scalability and margin growth.

In Q1 2025, Verano reported $210 million in revenue. This marked a strong increase compared to the prior year. The company recorded a net loss of $12 million for the quarter. However, adjusted EBITDA improved as gross margins expanded. Verano also generated $2 million in operating cash flow. Although capital expenditures remained high, the company managed costs effectively. Its balance sheet remains healthy, with reasonable levels of debt and cash on hand. Management continues to reinvest in new store openings and cultivation upgrades. These investments are expected to fuel future revenue growth. The company aims to reach profitability by late 2026. Analysts have highlighted Verano’s disciplined approach as a key advantage. By focusing on core markets and sustainable operations, it has built a resilient business model. Financial performance is expected to improve further as markets mature and efficiencies scale.

Leading U.S. Marijuana Stocks for May 2025

May 2025 presents a unique moment for cannabis investors. The U.S. industry is expanding amid evolving legalization trends. Companies like The Cannabist Company, Fluent, and Verano offer diverse exposure. Each firm operates in multiple states and controls a significant market share. Despite recent margin pressures, they are improving operational efficiency and cash flow. These names are well-positioned for long-term success in the cannabis sector. For investors, they represent top U.S. marijuana stocks to watch in 2025.

The post Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Charlotte’s Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF),  (“Charlotte’s Web” or the “Company”), a botanical wellness innovation company, today announced results for the quarter ended March 31, 2025, reporting its first year-over-year revenue increase in more than three years, building on the sequential quarterly growth trend achieved in 2024.

“Following three sequential quarters of improvement in 2024, Q1 delivered our first year-over-year revenue growth since 2021 – validating the transformation we initiated 18 months ago,” said Bill Morachnick, Chief Executive Officer. “Our upgraded e-commerce platform is converting more visitors, and new digital storefronts on Amazon, TikTok Shop, and Faire are widening our reach. An upcoming nationwide rollout with Whole Foods Market will strengthen our retail footprint. Operationally, we commenced initial in–house gummy production and, as part of our disciplined cost agenda, we mutually concluded our promotional rights agreement with MLB and associated costs. Coupled with robust innovation – including cannabinoid isolates and our new functional mushroom gummy line – we believe these initiatives position the Company to deliver top and bottom-line growth for 2025 and beyond.”

Erika Lind, Chief Financial Officer, added, “Our reengineered cost structure is now flowing through the P&L. Building on the positive traction from the prior quarters, we are structuring for further improvements in cost efficiency and cash flow. As a part of this effort, we have concluded some high-cost promotional sports agreements, thereby eliminating sizeable future cash outlays of more than $18 million over the next three years. This supports near-term cash flow and preserves long-term cash for further investment in innovation. Combined with our transitioning to in-house manufacturing and disciplined SG&A control, we anticipate further improvements to cash flow in 2025.”

First Quarter Business Review

Expansion of Mushroom Wellness Gummy Innovations
Following the successful Q4 2024 launch of its functional mushroom gummies targeting focus, stress, and energy, Charlotte’s Web will continue expanding its botanical wellness portfolio in 2025. The Company’s strategic diversification beyond CBD is gaining market traction with mushroom wellness products now available through multiple distribution channels, including Walmart.com, Amazon.com, and the Company’s direct-to-consumer platform.

E-Commerce Growth and Omnichannel Expansion
Building on the sequential gains recorded in 2024, Charlotte’s Web’s digital channels delivered year-over-year growth in Q1 2025. Order volume growth, stabilized average order values, new subscriber increases, and lower churn rates drove meaningful digital revenue growth and underscored brand loyalty. This performance reflects the past year’s technology and go-to-market enhancements: a unified brand architecture, an expanded product portfolio, data-driven segmentation, an upgraded e-commerce stack, and improved engagement tools such as SMS outreach and an influencer network that now reaches more than one million consumers.

The Company has widened its omnichannel footprint. Walmart.com added Charlotte’s Web’s new mushroom wellness gummies during the quarter, while strategic launches on Amazon, TikTok Shop, and Faire have dramatically broadened online reach. With additional categories and channels slated for launch in the coming quarters, the Company is well-positioned to meet consumers wherever they shop, diversifying revenue streams, and capturing incremental market share through improved digital discoverability.

Whole Foods Market Retail Distribution Launch
In a significant advancement of its retail expansion, the Company achieved a major milestone finalizing an agreement with Whole Foods Market to roll out products to more than 400 store locations nationwide. As part of this partnership, three isolate topical products will be available on shelves starting June 2025. This launch marks a significant step forward in making botanical wellness solutions more accessible to health-conscious consumers seeking trusted, plant-based alternatives.

Operational Efficiencies and Cost Management
Expense reductions initiated in 2024 continued to benefit operating performance, with year-over-year operating costs down 24.2%. Strengthening operations, Charlotte’s Web began preliminary in-house commercial production of gummies in Q2 2025, supporting gross margins and speed-to-market for new products. This production shift will enable the rapid development of new gummy blends.

“With successful expansion into new product categories, improving cash flow metrics, and enhanced operational efficiencies, Charlotte’s Web has a good start to 2025,” added Mr. Morachnick. “Our disciplined execution of strategic initiatives – from platform expansion to manufacturing optimization – positions us to build on this throughout 2025 and beyond, delivering value for shareholders and continued innovation for consumers.”

DeFloria Milestone
In the first quarter, DeFloria, Inc. – a joint entity established between Charlotte’s Web and Ajna BioSciences, with British American Tobacco as lead investor – received U.S. Food and Drug Administration (FDA) clearance to initiate Phase 2 clinical trials for its botanical pharmaceutical candidate, AJA001 Oral Solution, intended to treat irritability associated with autism spectrum disorder (“ASD”). AJA001 is formulated using Charlotte’s Web proprietary full-spectrum CBD extract derived from its patented cultivars. The FDA’s acceptance of DeFloria’s IND for AJA001 marks a significant milestone. In addition, Charlotte’s Web holds manufacturing rights for commercial supply when the drug is ultimately approved by the FDA, representing a potential opportunity that could be transformative for Charlotte’s Web over time.

On June 9, 2025, Charlotte’s Web and Ajna BioSciences will host an executive panel session at the Benzinga Cannabis Capital Conference in Chicago. As part of the panel discussion, Charlotte’s Web will showcase its partnership with DeFloria and AJA001’s clinical progress and therapeutic potential. For attendance information, contact IR@defloira.bio.

First Quarter 2025 Financial Review
The following table sets forth selected financial information for the periods indicated:

Three months ended

March 31,

U.S. $ millions, except per share data

2025

2024

Revenue

$

12.3

$

12.1

Cost of goods sold

$

6.1

$

5.2

Gross profit

6.2

6.9

Selling, general and administrative expenses

11.6

15.3

Operating loss

(5.4)

(8.4)

Change in fair value of financial instruments and other

(0.1)

(1.9)

Other income (expense) , net

(0.7)

0.6

Net loss

$

(6.2)

$

(9.7)

EPS basic and diluted

$

(0.04)

$

(0.06)

Adjusted EBITDA(1)

$

(2.8)

$

(3.9)

Assets:

Cash and cash equivalents

$

19.4

Total assets

$

108.0

Liabilities:

Long-term liabilities

$

68.5

Total liabilities

$

87.0

Quarterly revenue trend:

Q1

Q2

Q3

Q4

Q1

U.S. $ millions

2024

2024

2024

2024

2025

Total revenue

$ 12.1

$ 12.3

$ 12.6

$ 12.7

$ 12.3

Consolidated net revenue for the first quarter ended March 31, 2025, was $12.3 million, a year-over-year increase of 1.1% compared to $12.1 million in the first quarter of 2024. Propelled by the continued performance of the Company’s upgraded e-commerce platform, this represents the first period of year-over-year growth reported since Q2 2021 and builds upon a consecutive quarterly growth trend established in 2024. Introduced in mid-2024, the new platform has delivered measurable improvements in marketing effectiveness, customer engagement, and sales volumes. The Company also continues to generally outperform its peers in retail category benchmarks, reflecting the strength of its recent product innovations and the effectiveness of its strategic retail partnerships.

Gross profit in Q1 2025 was $6.2 million, or 50.8% of revenue, compared to gross profit of $6.9 million, or 57.0% of revenue, in Q1 2024. The prior year included temporary items favorable to gross margin. The Company models forward gross margin percentages to continue in the low 50s, supported partly by the transition to in-house production of gummies, followed by topical products over time.

Total selling, general, and administrative (“SG&A”) expenses in the quarter were $11.6 million, a 24.2% improvement from $15.3 million in Q1 2024. Stringent expense controls were implemented over the past year and remain a central focus in 2025.

Net loss for the first quarter of 2025 was $6.2 million, or ($0.04) per share basic and diluted, compared to a net loss of $9.7 million, or ($0.06) per share basic and diluted, for the first quarter of 2024.

Excluding depreciation, amortization and other non-cash items, Charlotte’s Web reported negative Adjusted EBITDA1 for the first quarter of 2025 of $2.8 million, a $1.1 million improvement compared to negative Adjusted EBITDA of $3.9 million in the first quarter of 2024.

Balance Sheet and Cash Flow
Net cash used for operations in the first quarter of 2025 was $2.8 million. The Company’s cash and working capital as of March 31, 2025, were $19.4 million and $25.5 million, respectively, compared to $22.6 million and $31.1 million as of December 31, 2024, respectively.

“With cash reserves exceeding $19 million and our anticipated cash flow improvements for this year, we are confident our balance sheet is sufficient to support growth for 2025 and beyond,” said Mrs. Lind.

Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s consolidated financial statements and accompanying notes for the three month periods ended March 31, 2025, and 2024, and related management’s discussion and analysis of financial condition and results of operations (“MD&A”), are reported in the Company’s 10-Q filing on the Securities and Exchange Commission website at www.sec.gov and on SEDAR+ at www.sedarplus.ca and will be available on the Investor Relations section of the Company’s website at https://investors.charlottesweb.com.

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and market leader in hemp extract wellness that includes Charlotte’s Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD. Charlotte’s Web branded premium quality full-spectrum CBD extract products start with proprietary hemp genetics that are North American farm-grown using organic and regenerative cultivation practices. The Company’s hemp extracts have naturally occurring botanical compounds including cannabidiol (“CBD”), CBN, CBC, CBG, terpenes, flavonoids, and other beneficial compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte’s Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte’s Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and are available online through the Company’s website at www.charlottesweb.com.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF”.

(1)

Non-GAAP Measures: The press release contains non-GAAP measures, including EBITDA and Adjusted EBITDA. Please refer to the section in the tables captioned “Non-GAAP Measures” below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

Forward-Looking Information

Certain information provided herein constitutes forward-looking statements or information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as “may”, “will”, “should”, “could”, “anticipate”, “expect”, “project”, “estimate”, “forecast”, “plan”, “intend”, “target”, “believe” and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance, and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions, expected future development, and other factors that it believes are appropriate and reasonable.

Specifically, this press release contains forward-looking statements relating to, but not limited to: organizational changes, marketing plans and operational platform upgrades, and the impact of these initiatives on retail expansion, operational efficiencies, cash flow,‎ revenue and e-commerce monetization; expectations relating to IT upgrades, marketing optimization and operational integrations; product expansion activities and the corresponding ‎results thereof; sales volume and gross margin expectations; anticipated timing for, and business impact of, in-house manufacturing of topical ‎and gummy products; ‎the impact of the Company’s product innovations on product development; regulatory developments and the impact of developments on both consumer action and the Company’s opportunities and operations; activities relating to, and sponsorship of, legislation to advance regulatory framework; the impact of insourcing on operating margins, capital expenditures and R&D; anticipated consumer trends and corresponding product innovation; anticipated future financial results; the Company’s ability to increase online traffic and demographic exposure through new products and marketing and omni-channel expansion; and the impact of certain activities on the Company’s business and financial condition and anticipated trajectory; launch of products in Whole Foods; continued product placement on various product channels; anticipated development of new products; the outcomes from DeFloria’s clinical trials, including commercial opportunities for Charlotte’s Web.

The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to: regulatory regime changes; anticipated product development and sales; the success of sales and marketing activities; product development and production expectations; outcomes from R&D activities; the Company’s ability to deal with adverse growing conditions in a timely and cost-effective manner; the availability of qualified and cost-effective human resources; compliance with contractual and regulatory obligations and requirements; availability of adequate liquidity and capital to support operations and business plans; and expectations around consumer product demand. In addition, the forward-looking statements are subject to risks and uncertainties pertaining to, among other things: supply and distribution chains; the market for the Company’s products; revenue fluctuations; regulatory changes; loss of customers and retail partners; retention and availability of talent; competing products; share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; economic and political considerations; and including but not limited to those risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and other risk factors contained in other filings with the Securities and Exchange Commission available on www.sec.gov and filings with Canadian securities regulatory authorities available www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty, as these are interdependent, and the Company’s future course of action depends on management’s assessment of all information available at the relevant time.

Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

CHARLOTTE’S WEB HOLDINGS, INC.CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars, except share and per share amounts)

March 31,

December 31,

2025 (unaudited)

2024

ASSETS

Current assets:

Cash and cash equivalents

$ 19,357

$ 22,618

Accounts receivable, net

1,531

1,263

Inventories, net

18,916

18,907

Prepaid expenses and other current assets

4,201

4,194

Total current assets

44,005

46,982

Property and equipment, net

25,758

26,337

License and media rights

12,717

13,691

Operating lease right-of-use assets, net

12,404

12,876

Investment in unconsolidated entity

10,700

10,800

SBH purchase option and other derivative assets

970

1,075

Intangible assets, net

1,003

1,049

Other long-term assets

466

632

Total assets

$ 108,023

$ 113,442

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$ 3,943

$ 3,426

Accrued and other current liabilities

4,764

5,246

Lease obligations – current

1,844

2,055

License and media rights payable – current

7,937

5,209

Total current liabilities

18,488

15,936

Convertible debenture

44,753

43,631

Lease obligations

13,257

13,652

License and media rights payable

9,227

11,809

Derivative and other long-term liabilities

1,236

1,327

Total liabilities

86,961

86,355

Commitments and contingencies

Shareholders’ equity:

Common shares, nil par value; unlimited shares authorized; 158,009,541 and
158,009,541 shares issued and outstanding as of March 31, 2025 and December
31, 2024

1

1

Additional paid-in capital

328,842

328,655

Accumulated deficit

(307,781)

(301,569)

Total shareholders’ equity

21,062

27,087

Total liabilities and shareholders’ equity

$ 108,023

$ 113,442

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands of U.S. dollars, except share and per share amounts)

Three Months Ended March 31,
(unaudited)

2025

2024

Revenue

$ 12,262

$ 12,124

Cost of goods sold

6,032

5,213

Gross profit

6,230

6,911

Selling, general, and administrative expenses

11,578

15,280

Operating loss

(5,348)

(8,369)

Change in fair value of financial instruments

(126)

(1,860)

Other income (expense), net

(738)

611

Loss before provision for income taxes

$ (6,212)

$ (9,618)

Income tax expense

—

(16)

Net loss

$ (6,212)

$ (9,634)

Per common share amounts

Net loss per common share, basic and diluted

$ (0.04)

$ (0.06)

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of U.S. dollars, except share amounts)

Common Shares

Additional
Paid-in
Capital

Accumulated
Deficit

Total
Shareholders’
Equity

Shares

Amount

Balance—December 31, 2024

158,009,541

$ 1

$ 328,655

$ (301,569)

$ 27,087

Common shares issued upon vesting of restricted share units,
net of withholding

—

—

—

—

—

Share-based compensation

—

—

187

—

187

Net loss

—

(6,212)

(6,212)

Balance—March 31, 2025

158,009,541

$ 1

$ 328,842

$ (307,781)

$ 21,062

Balance—December 31, 2023

154,332,366

$ 1

$ 327,280

$ (271,723)

$ 55,558

Common shares issued upon vesting of restricted share units,
net of withholding

2,895,489

—

(98)

—

(98)

Share-based compensation

—

842

—

842

Net loss

—

(9,634)

(9,634)

Balance—March 31, 2024

157,227,855

$ 1

$ 328,024

$ (281,357)

$ 46,668

CHARLOTTE’S WEB HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of U.S. dollars)

Three Months Ended March 31,
(unaudited)

2025

2024

Cash flows from operating activities:

Net loss

$ (6,212)

$ (9,634)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

2,449

2,493

Change in fair value of financial instruments

126

1,860

Convertible debenture and other accrued interest

868

1,015

Changes in right-of-use assets

473

443

Share-based compensation

187

842

Other

126

(956)

Changes in operating assets and liabilities:

Accounts receivable, net

(394)

98

Inventories, net

19

(1,026)

Prepaid expenses and other current assets

28

150

License and media rights

—

(2,500)

Operating lease obligations

(605)

(551)

Accounts payable, accrued and other liabilities

71

663

Other operating assets and liabilities, net

96

(76)

Net cash used in operating activities

(2,768)

(7,179)

Cash flows from investing activities:

Purchases of property and equipment and intangible assets

(521)

(2,060)

Proceeds from sale of assets

28

27

Net cash used in investing activities

(493)

(2,033)

Cash flows from financing activities:

Other financing activities

—

(98)

Net cash used in financing activities

—

(98)

Net decrease in cash and cash equivalents

(3,261)

(9,310)

Cash and cash equivalents —beginning of period

22,618

47,820

Cash and cash equivalents —end of period

$ 19,357

$ 38,510

Non-cash activities:

Non-cash purchase of property and equipment and intangible assets

$ (83)

$ (374)

(1) Non-GAAP Measures – EBITDA and Adjusted EBITDA
Earnings before interest, taxes, depreciation, and amortization (“EBITDA”) is not a recognized performance measure under U.S. GAAP. The term EBITDA consists of net loss and excludes interest, taxes, depreciation, and amortization. Adjusted EBITDA also excludes other non-cash items such as changes in fair value of financial instruments (Mark-to-Market), Share-based compensation, and impairment of assets. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The non-GAAP financial measures do not have a standardized meaning prescribed under U.S. GAAP and, therefore, may not be comparable to similar measures presented by other issuers. The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.

Adjusted EBITDA for the three months ended March 31, 2025, and 2024 is as follows:

Charlotte’s Web Holdings, Inc.

Statement of Adjusted EBITDA

(In Thousands)

Three Months Ended
March 31,
(unaudited)

U.S. $ Thousands

2025

2024

Net loss

$

(6,212)

$

(9,618)

Depreciation of property and equipment and amortization of intangibles

2,449

2,493

Interest expense

685

487

Income tax expense

16

EBITDA

(3,078)

(6,622)

Share-based compensation

187

842

Mark-to-market financial instruments

126

1,860

Adjusted EBITDA

$

(2,765)

$

(3,920)

SOURCE Charlotte’s Web Holdings, Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/14/c3289.html

The post Charlotte’s Web Holdings, Inc. (CWBHF) Reports Year-Over-Year Growth For Q1 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis industry has faced significant challenges in recent years, leading to a downturn in marijuana stock prices. Despite the current market conditions, there may be a strategic opportunity for investors. With how low the sector has fallen, this risk vs reward opportunity could be profitable. The cannabis sector needs a big momentum change and an impactful catalyst to do so.

This is where many feel the passing of federal reform will be the dominant shift for most marijuana stocks. Market corrections are often where real value is found. Cannabis stocks are currently trading at historically low price-to-sales and price-to-book ratios. What this means is investors can find top marijuana stocks to buy at steal valuations. Now, most of the time it is a waiting game as to when a volatile pop will occur, so long-term planning is what’s occurring.

In short, while the cannabis sector has faced headwinds, current lows may not reflect the long-term potential of the industry. For investors willing to be patient, the current downtrend could be a rare chance to buy low before the next wave of growth begins. Just make sure you do your research and develop a trading strategy that works for you. Below are several marijuana stocks to watch today.

Marijuana Stocks For Your 2025 Portfolio

1. FLUENT Corp. (OTC:CNTMF)
2. Glass House Brands Inc.(OTC:GLASF)
3. Ascend Wellness Holdings, Inc. (OTC:AAWH)

FLUENT Corp.

FLUENT Corp., through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

In recent news, the company released New York Minute, a bold new addition to its MOODS vaporizer portfolio. The new offering will be available in two convenient All-in-One device formats: a 1g Mini and a 0.5g Dash, catering to consumers who seek portability, performance,e and taste.

Words From The CEO

“New York sets the tone for culture, innovation, and lifestyle—and we wanted to create a vape product that connects with that essence,” said Robert Beasley, CEO of FLUENT.”

Glass House Brands Inc.

Glass House Brands Inc. operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.

The company has recently announced in partnership with LEEF Brands Inc. This Management Services Agreement Glass House will manage operations of LEEF’s Palm Desert, California, dispensary, “The Leaf El Paseo,” on behalf of LEEF. Glass House will assume daily management responsibilities of The Leaf El Paseo.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Ascend Wellness Holdings, Inc.

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States.

In recent updates, the company has reported its Q1 2025 earnings.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

Financial Highlights
Revenue:

• Total net revenue declined 5.9% quarter-over-quarter to $128.0 million.
• Retail revenue decreased 6.6% quarter-over-quarter to $84.4 million.
• Wholesale revenue decreased 4.4% quarter-over-quarter to $43.6 million.
  Net Loss:
• Net loss of $19.3 million in Q1 2025 compared to net loss of $16.8 million in Q4 2024.

The post These Cannabis Stocks Could Pay Off Big In The Future appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The current state of marijuana stocks could keep some people discouraged.
With no federal reform or bills to ease tax burdens and improve banking access, this has led to a downtrend. A volatile wave of downward trading has plagued the sector for some time. People see that money is being made for legal operators, but still, no one feels as safe and protected as they should be.

With more than half of the US and other global regions legalizing cannabis, you would think people would see it as any other business. State-level efforts are being made to help manage market saturation and taxation, as some companies are not as successful as others. Investors are staying cautious, as the sector could see further consolidation, as only the most resilient companies will survive. With that said, there is still the possibility to see gains, even in a time like now.

The market for cannabis stocks has fallen so low that anyone can pick up shares are much lower prices. They see it as a risk of buy and hold and wait to see what comes of it. Certain MSOs are seeing big revenue, and they continue to move upward as a business. This is seen as a sign that there is potential down the road to see better profits. For now, it’s a waiting game as more people consider taking a look at the best marijuana stocks to watch in 2025.

Top Marijuana Stocks In The Market

1. Tilray Brands, Inc. (NASDAQ:TLRY)
2. Cronos Group Inc.(NASDAQ:CRON)
3. Village Farms International, Inc. (NASDAQ:VFF)

Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

The company recently announced the highly anticipated re-release of Delayed Pilsner. This is a beer crafted to soothe the soul of every New Yorker facing the inevitable delays of city life.

Words From The Company

“We understand the challenges of city life and the frustration that comes with delays,” said Carrie Shafir, Senior Brand Director, Tilray Beverages. “Delayed Pilsner is our way of helping New Yorkers find a moment of peace amidst the chaos. It’s a beer that’s not just refreshing but also comforting.”

[Read More] Investing in Green: Top U.S. Marijuana Stocks for May 2025

Cronos Group Inc.

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

On April 28th, the company announced it will hold a virtual 2025 annual meeting of shareholders. With this, Cronos has set June 20, 2025, at 11:00 a.m. ET. as the date and time of the conference. Cronos will be conducting the meeting in a virtual-only format via live audio webcast.

[Read More] Here Is How The Cannabis Industry Impacts The Public Sector

Village Farms International, Inc.

Village Farms International, Inc., together with its subsidiaries, produces, markets, and distributes greenhouse-grown tomatoes, bell peppers, cucumbers, and mini-cukes in North America.

In more recent company updates, it looks like Village Farms is going to reschedule its Q1 conference call. The company is now planning for Tuesday, May 13, 2025, at 8:30 a.m. ET. Participants can access the conference call via a webcast at Village Farms First Quarter 2025 Conference Call Webcast or on the Company website.

The post Top 3 Marijuana Stocks For Better Investing 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry is poised for continued growth in 2025. Market estimates suggest it could exceed $45 billion in total value this year. This growth is fueled by rising consumer demand and expanding access in newly legalized states. Recently, multiple states have advanced adult-use legislation, creating fresh momentum. As legalization efforts gain traction, more companies are entering the market. This trend provides new opportunities for investors focused on undervalued cannabis stocks. Many penny stocks in the sector are gaining attention due to strong volume and low price points. Therefore, marijuana penny stocks could offer explosive upside for short-term and long-term traders alike.

However, these stocks often come with heightened volatility. For this reason, technical analysis becomes essential. Traders should focus on support and resistance levels, trend confirmation, and trading volume. Additionally, proper risk management is critical. Always use stop-loss levels and size positions based on account risk. While potential gains can be substantial, downside moves can also be sharp. Consequently, disciplined strategies are key when trading marijuana penny stocks.

Marijuana Stocks With Breakout Charts

The U.S. cannabis sector continues to show long-term promise despite recent volatility. Several stocks are now catching the attention of traders and investors. This May, three companies stand out due to their size, recent expansion, and updated financial performance. These include The Cannabist Company, Cansortium Inc., and Verano Holdings. Each has made operational changes, opened new locations, or shifted strategy to gain market share.

As the industry evolves, picking stocks with strong fundamentals becomes more important. Regulatory news, consumer demand, and retail access will drive momentum. These three operators are expanding across high-growth states like Florida, Pennsylvania, and Illinois. With smart technical analysis and proper risk management, they may offer favorable setups. Now let’s look at each company in detail, starting with The Cannabist Company.

[Read More] Here Is How The Cannabis Industry Impacts The Public Sector

Top 3 Marijuana Stocks to Watch in May 2025

1. The Cannabist Company Holdings Inc. (OTC: CBSTF)
2. Cansortium Inc. (OTC: CNTMF)
3. Verano Holdings Corp. (OTC: VRNOF)

The Cannabist Company Holdings Inc. (CBSTF)

The Cannabist Company is one of the largest vertically integrated cannabis operators in the United States. Formerly known as Columbia Care, it runs dispensaries in 14 states. Its largest presence is in Florida, New York, and Virginia. The company operates 67 active dispensaries nationwide. In addition, it controls 17 cultivation and processing facilities.

The Cannabist retail brand offers a consistent experience across locations. It features premium cannabis products, including flower, vape cartridges, and capsules. The company owns and promotes in-house product lines such as Triple Seven and Seed & Strain. It aims to build customer loyalty through rewards and digital platforms. Recently, management has focused on streamlining operations and reducing costs. This includes closing underperforming dispensaries in mature markets.

Latest Financials

In its latest quarterly report, the company reported a slight decline in total revenue. Sales dropped due to pricing pressure and store closures. However, management has taken active steps to stabilize margins. This includes trimming SG&A expenses and exiting lower-margin states. Net loss improved compared to the prior year, showing better efficiency.

The company also restructured a significant portion of its outstanding debt. This reduces interest expenses and frees up cash for expansion. Gross profit margins improved as production costs fell in newer facilities. Overall, the balance sheet shows signs of recovery. If trends continue, revenue could stabilize by the second half of 2025. Investors are watching closely for guidance in the next earnings release.

[Read More] Investing in Green: Top U.S. Marijuana Stocks for May 2025

Cansortium Inc. (CNTMF)

Cansortium Inc., now doing business as Fluent, is a Florida-based cannabis company. It focuses on high-growth medical markets with strong consumer demand. The company’s largest presence is in Florida, where it operates over 30 dispensaries. It also has licenses in Texas, Pennsylvania, and New York. The Fluent brand emphasizes clean cultivation and pharmacist-led guidance.

Each Fluent location offers a wide selection of products, including tinctures, oils, vapes, and edibles. The company prides itself on professional service and clinical support. It continues to expand its cultivation capacity, targeting efficiency and quality. Plans include increasing canopy space and upgrading extraction capabilities. Florida remains the core growth engine, but expansion into Pennsylvania offers upside potential.

Latest Financials

Cansortium posted double-digit revenue growth year over year. The gains were driven mainly by Florida sales. Margins expanded as operating costs were held steady during the quarter. EBITDA also improved, thanks to higher average ticket prices and better product mix. The company remains cash flow positive and continues to pay down debt.

Capex has been controlled, with capital directed to proven markets. Management expects more growth from upcoming dispensary openings. Their financial forecast indicates rising revenue over the next two quarters. Key risks include regulatory delays and slower-than-expected market development in new regions. However, strong execution in Florida gives the company a firm foundation. Investors view this as one of the more stable micro-cap operators in the U.S.

[Read More] Top Marijuana Stocks With Upside Potential In The Market

Verano Holdings Corp. (VRNOF)

Verano Holdings is a major cannabis operator with a strong footprint across the U.S. Headquartered in Chicago, it is active in 13 states. Its largest market is Florida, where it now runs 81 dispensaries. The company also has a growing presence in New Jersey, Illinois, and Arizona. Its two key retail brands are Zen Leaf and MÜV.

Verano offers a full line of cannabis products, including flower, pre-rolls, vapes, and infused gummies. The company owns several in-house brands designed to appeal to different customer segments. These include Savvy, BITS, Avexia, and Encore. It has over 1 million square feet of cultivation space. The business is vertically integrated, giving it control over pricing, distribution, and supply chain. This helps maintain high product consistency across states.

Latest Financials

Verano reported annual revenue approaching $850 million last year. It remains one of the top earners in the cannabis sector. The company has faced recent net losses due to high operating costs and depreciation. However, adjusted EBITDA remains positive. Cost-cutting programs are underway to improve profitability. The Florida market has been especially strong, contributing a large share of total revenue.

New dispensaries continue to open on a monthly basis. The company forecasts further growth in adult-use states like New Jersey and Connecticut. It is also investing in automation to lower production costs. Debt levels are being managed carefully, and liquidity appears stable. Analysts are looking for signs of margin recovery in upcoming quarters. Long-term, Verano is viewed as a potential consolidator in the U.S. market.

[Read More] High Potential: Canadian Cannabis Stocks Making Waves in May 2025

Top Pot Penny Stocks to Watch Closely in May 2025

The cannabis industry remains volatile but filled with opportunity. Companies with strong fundamentals and multistate operations are best positioned for the future. The Cannabist Company, Cansortium Inc., and Verano Holdings all meet those criteria. Each is expanding in high-demand states and actively improving financials. With careful chart analysis and smart entry points, these stocks could offer attractive setups in May 2025

The post Best Cannabis Penny Stocks for Your May 2025 Trading Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to gain momentum as more states legalize marijuana for recreational and medical use. As of this week, over 20 states now allow adult-use cannabis, and more states are actively exploring legislation. The market is expected to reach over $45 billion in total value by 2025. This sustained growth creates new opportunities for investors looking to enter the space. Recently, there has been renewed discussion about federal reform. Lawmakers are revisiting cannabis rescheduling and expanding access to banking for cannabis businesses. These headlines have sparked renewed interest in marijuana stocks. As a result, traders are now watching several U.S. cannabis companies that could benefit from regulatory momentum.

However, identifying strong opportunities requires more than reading the news. Technical analysis is essential when evaluating short-term entries in volatile sectors like cannabis. Traders should look for patterns, volume spikes, and key support levels. It’s also critical to use proper risk management. Stop losses, trade sizing, and clear entry targets can help limit downside. Even the strongest chart setup can fail without discipline. As the week unfolds, combining these strategies with a solid watchlist may help traders stay focused and avoid emotional decision-making.

In May 2025, investors will continue searching for companies with strong growth potential, strategic positioning, and improving financials. Three marijuana stocks stand out this month: Glass House Brands Inc. (GLASF), The Cannabist Company Holdings Inc. (CBSTF), and Ascend Wellness Holdings Inc. (AAWH). Each company brings unique strengths to the table, including strong retail footprints, cultivation capabilities, and innovative branding. Below is a detailed breakdown of each company’s market presence and financial performance.

[Read  More]  Best Cannabis Penny Stocks to Add to Your May 2025 Watchlist

Top U.S. Marijuana Stocks to Watch in May 2025

1. Glass House Brands Inc. (OTC: GLASF)
2. The Cannabist Company Holdings Inc. (OTC: CBSTF)
3. Ascend Wellness Holdings Inc. (OTC: AAWH)

Glass House Brands Inc. (GLASF)

Glass House Brands Inc. is a vertically integrated cannabis company based in California. The company owns and operates several dispensaries across the state under various banners, including The Farmacy and Natural Healing Center. One of its most notable assets is a massive greenhouse cultivation facility located in Ventura County. This facility is among the largest in the United States, spanning over five million square feet. The company uses this facility to produce high-quality cannabis at scale.

Currently, Glass House operates more than a dozen dispensaries across California. The company’s primary focus remains on the California adult-use market, where it sees significant long-term opportunity. By combining large-scale cultivation with branded retail outlets, Glass House continues to build its presence in one of the most competitive cannabis markets in the U.S. Additionally, its retail strategy includes premium positioning and community-focused stores that appeal to both newcomers and experienced users.

Financially, Glass House has made considerable progress. In recent quarters, the company posted year-over-year revenue growth, driven by an increase in both wholesale and retail sales. The company has also focused on reducing its cost per pound of production. By operating its large-scale greenhouse efficiently, it has improved margins significantly. This focus on cost control has helped the company generate positive adjusted EBITDA in recent quarters.

Additionally, Glass House expects continued growth throughout 2025. Management has projected increased output from its cultivation facility and additional store openings. These developments are expected to drive revenue to new highs. The company is also investing in branded product lines, which offer higher margins and stronger customer loyalty. Despite challenges in the California market, Glass House remains well-positioned due to its scale and brand strength.

[Read More] Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025

The Cannabist Company Holdings Inc. (CBSTF)

The Cannabist Company Holdings Inc., formerly known as Columbia Care, is a multi-state operator with a wide footprint across the U.S. The company operates dispensaries under the Cannabist brand in both medical and adult-use markets. It is currently active in 14 states and manages nearly 100 facilities. This includes more than 70 dispensaries and over 20 cultivation and processing centers. The Cannabist brand aims to deliver a premium cannabis experience to consumers through innovative retail design and curated product offerings.

The company’s largest presence includes states like Florida, New York, and Virginia. It serves both medical patients and recreational customers with a broad selection of flower, edibles, tinctures, and concentrates. Additionally, it owns and distributes several in-house brands. These include Seed & Strain, Triple Seven, and Hedy, each targeting different consumer segments. Through its wide reach and vertical integration, the Cannabist Company seeks to maximize efficiencies and build brand recognition nationwide.

On the financial side, the company has faced some recent headwinds. Revenue saw a modest decline year-over-year due to regulatory delays and pricing pressure in several markets. However, the company has taken action to improve its balance sheet. Management has focused on debt restructuring and improving operational efficiencies. The extension of certain credit terms has allowed the company to reduce financial pressure and plan more effectively for long-term growth.

Although margins tightened slightly in 2024, cost-cutting measures and better inventory management have helped stabilize earnings. Additionally, management is targeting future profitability through improved dispensary performance and streamlined operations. As new adult-use markets open and regulations ease, the Cannabist Company may be well-positioned to regain revenue momentum. It remains a stock to watch closely, especially if broader cannabis reform gains traction at the federal level.

[Read More] 3 Marijuana Stocks For The Long-Term Investing

Ascend Wellness Holdings Inc. (AAWH)

Ascend Wellness Holdings Inc. is another top-tier cannabis operator with a strong footprint in limited-license states. The company operates in seven states: Illinois, Massachusetts, Michigan, New Jersey, Ohio, Pennsylvania, and Maryland. Ascend owns and operates cultivation facilities, processing centers, and over 30 retail dispensaries across these markets. The company is known for its vertically integrated structure and diverse product portfolio, which includes edibles, concentrates, flower, and vapes.

Ascend’s retail strategy focuses on high-traffic locations and premium store layouts. The company’s in-house brands include Ozone and Simply Herb. These brands cater to both value-conscious customers and those seeking premium products. Ascend also has a strong wholesale operation, supplying products to third-party dispensaries in addition to its own stores. The company’s strategic positioning in high-growth, tightly regulated markets gives it a competitive edge.

From a financial perspective, Ascend has delivered consistent top-line growth. In 2024, the company posted an annual revenue increase compared to the prior year. This growth was supported by new store openings and increased cultivation yields. However, like many cannabis operators, Ascend reported a net loss as it continued to invest in infrastructure and expansion. Despite this, management emphasized a strong focus on achieving profitability through margin improvements and operating leverage.

The company also initiated a share repurchase program in late 2024. This was seen as a sign of management’s confidence in long-term value creation. In 2025, Ascend is expected to continue expanding in New Jersey and Maryland, where adult-use markets are gaining traction. These expansions could significantly boost revenue and brand visibility. With disciplined growth and operational improvements underway, Ascend remains a strong candidate for long-term investors in the cannabis sector.

[Read More] These 3 Marijuana Stocks Could Be The Winners You Need

Capitalizing on Cannabis Gains: Investment Approaches Post-Upside

As the U.S. marijuana industry matures, companies with strong fundamentals and strategic market positions are beginning to emerge as clear leaders. Glass House Brands, The Cannabist Company, and Ascend Wellness each offer a different path to growth. Whether through large-scale cultivation, nationwide branding, or disciplined state expansion, these companies are positioned to capitalize on the evolving regulatory and consumer landscape. For investors looking at cannabis exposure in May 2025, these three stocks are well worth a spot on the watchlist.

The post Cannabis Stocks on the Rise: Key Players to Watch Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..